Vault-13

Venrock Adviser, LLC

NEW YORK, NY · CIK 1615982 · 13F filing filed 2022-02-14

SEC-registered investment adviser since 2014 · limited liability company

As an employer

Where they work

people there (dot area)number not reportedmain officeHover or tap a dot. Australian and UK companies are placed at their business or registered address, with their staff across the whole country.

Offices

From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.

CityCountryPeople
New York, NY (main office)United States United Statesabout 11
Palo Alto, CAUnited States United States

Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.

$731.5m reported value -6.0% vs Q3 2021
26positions
70.9%in top 10
3 new 6 added 5 reduced 3 sold out vs Q3 2021

Holdings, Q4 2021

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 INSTIL BIO INC COM COM 6,865,076 $117.5m16.06% 16.06% UnchangedShares held: Q1 2021 6.9m, Q2 2021 6.9m, Q3 2021 6.9m, Q4 2021 6.9m
2 ACLARIS THERAPEUTICS INC COM ACRS ACRS 4,563,962 $66.4m9.07% 9.07% UnchangedShares held: Q1 2021 3.7m, Q2 2021 4.6m, Q3 2021 4.6m, Q4 2021 4.6m
3 TRAVERE THERAPEUTICS INC COM TVTX TVTX 1,994,997 $61.9m8.47% 8.47% AddedShares held: Q1 2021 0, Q2 2021 0, Q3 2021 1.7m, Q4 2021 2.0m +262.6k +262,587 15.2%
4 RELMADA THERAPEUTICS INC COM RLMD RLMD 2,270,072 $51.1m6.99% 6.99% AddedShares held: Q1 2021 853.2k, Q2 2021 1.4m, Q3 2021 1.4m, Q4 2021 2.3m +882.4k +882,352 63.6%
5 GH RESEARCH PLC ORDINARY SHARES GHRS GHRS 2,021,985 $47.2m6.45% 6.45% AddedShares held: Q1 2021 0, Q2 2021 1.3m, Q3 2021 1.6m, Q4 2021 2.0m +379.7k +379,689 23.1%
6 AADI BIOSCIENCE INC COM WHWK WHWK 1,529,402 $36.9m5.05% 5.05% UnchangedShares held: Q1 2021 0, Q2 2021 0, Q3 2021 1.5m, Q4 2021 1.5m
7 VIRIDIAN THERAPEUTICS INC COM VRDN VRDN 1,852,919 $36.6m5.01% 5.01% AddedShares held: Q1 2021 19.5k, Q2 2021 19.5k, Q3 2021 19.5k, Q4 2021 1.9m +1.8m +1,833,424 9404.6%
8 MARINUS PHARMACEUTICALS INC COM NEW MRNS MRNS 2,880,096 $34.2m4.68% 4.68% AddedShares held: Q1 2021 2.6m, Q2 2021 2.6m, Q3 2021 2.6m, Q4 2021 2.9m +238.3k +238,287 9.0%
9 CELLDEX THERAPEUTICS INC NEW COM NEW CLDX CLDX 865,116 $33.4m4.57% 4.57% ReducedShares held: Q1 2021 1.2m, Q2 2021 1.2m, Q3 2021 1.1m, Q4 2021 865.1k -233.1k -233,058 -21.2%
10 TRICIDA INC COM TCDA TCDA 3,494,851 $33.4m4.57% 4.57% AddedShares held: Q1 2021 0, Q2 2021 0, Q3 2021 390.7k, Q4 2021 3.5m +3.1m +3,104,144 794.5%
11 LIANBIO SPONSORED ADS LIANY LIANY 5,378,341 $33.1m4.53% 4.53% NewShares held: Q1 2021 0, Q2 2021 0, Q3 2021 0, Q4 2021 5.4m
12 VISTAGEN THERAPEUTICS INC COM NEW VTGN VTGN 16,047,286 $31.3m4.28% 4.28% UnchangedShares held: Q1 2021 16.3m, Q2 2021 16.0m, Q3 2021 16.0m, Q4 2021 16.0m
13 CHINOOK THERAPEUTICS INC COM ADRO ADRO 1,283,821 $20.9m2.86% 2.86% NewShares held: Q1 2021 0, Q2 2021 0, Q3 2021 0, Q4 2021 1.3m
14 GRAPHITE BIO INC COM GRPH GRPH 1,612,617 $20.0m2.74% 2.74% UnchangedShares held: Q1 2021 0, Q2 2021 1.6m, Q3 2021 1.6m, Q4 2021 1.6m
15 NUVALENT INC COM COM 803,951 $15.3m2.09% 2.09% UnchangedShares held: Q1 2021 0, Q2 2021 0, Q3 2021 804.0k, Q4 2021 804.0k
16 KINNATE BIOPHARMA INC COM KNTE KNTE 773,014 $13.7m1.87% 1.87% ReducedShares held: Q1 2021 1.5m, Q2 2021 1.5m, Q3 2021 1.5m, Q4 2021 773.0k -700.0k -700,000 -47.5%
17 ATHIRA PHARMA INC COM COM 1,000,000 $13.0m1.78% 1.78% ReducedShares held: Q1 2021 1.7m, Q2 2021 1.5m, Q3 2021 1.2m, Q4 2021 1.0m -196.2k -196,196 -16.4%
18 CENTESSA PHARMACEUTICALS PLC SPONSORED ADS SPONSORED ADS 1,127,272 $12.7m1.74% 1.74% UnchangedShares held: Q1 2021 0, Q2 2021 1.1m, Q3 2021 1.1m, Q4 2021 1.1m
19 ATYR PHARMA INC COM NEW ATYR ATYR 1,565,000 $11.7m1.60% 1.60% UnchangedShares held: Q1 2021 0, Q2 2021 0, Q3 2021 1.6m, Q4 2021 1.6m
20 COGENT BIOSCIENCES INC COM COGT COGT 1,088,817 $9.3m1.28% 1.28% UnchangedShares held: Q1 2021 1.1m, Q2 2021 1.1m, Q3 2021 1.1m, Q4 2021 1.1m
21 AFFIMED N V COM COM 1,428,571 $7.9m1.08% 1.08% NewShares held: Q1 2021 0, Q2 2021 0, Q3 2021 0, Q4 2021 1.4m
22 OLEMA PHARMACEUTICALS INC COM OLMA OLMA 816,651 $7.6m1.04% 1.04% ReducedShares held: Q1 2021 1.5m, Q2 2021 1.5m, Q3 2021 1.5m, Q4 2021 816.7k -719.5k -719,542 -46.8%
23 CVRX INC COM CVRX CVRX 533,370 $6.5m0.89% 0.89% UnchangedShares held: Q1 2021 0, Q2 2021 633.4k, Q3 2021 533.4k, Q4 2021 533.4k
24 AKOYA BIOSCIENCES INC COM AKYA AKYA 400,000 $6.1m0.84% 0.84% UnchangedShares held: Q1 2021 0, Q2 2021 400.0k, Q3 2021 400.0k, Q4 2021 400.0k
25 ASTRIA THERAPEUTICS INC COM CATB CATB 538,999 $2.9m0.40% 0.40% UnchangedShares held: Q1 2021 0, Q2 2021 0, Q3 2021 539.0k, Q4 2021 539.0k
26 CORVUS PHARMACEUTICALS INC COM CRVS CRVS 250,000 $603.0k0.08% 0.08% ReducedShares held: Q1 2021 0, Q2 2021 0, Q3 2021 3.4m, Q4 2021 250.0k -3.2m -3,177,461 -92.7%

Sold out since Q3 2021

SecurityTickerShares held beforeValue then
ALTIMMUNE INC ALT ALT 3,800,000 $43.0m3.8m shares
CULLINAN THERAPEUTICS INC CGEM CGEM 706,050 $15.9m706.0k shares
PHARVARIS N V PHVS PHVS 552,882 $9.8m552.9k shares